pharmaceuticals for the treatment of inflammatory problems and diseases; pharmaceuticals for the treatment of ocular inflammatory diseases, eye dryness and inflammation, and uveitis; pharmaceuticals for the treatment of one or more than one eye condition, eye disease, eye injury, diseases of the posterior segment including diabetic retinopathy, macular edema, macular degeneration or a combination of one or more than one eye condition, eye disease, eye injury, diseases of the posterior segment...